Y-Intercept (HK)’s AngioDynamics ANGO Stock Holding History

Y-Intercept (HK)’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$602K	Sell	46,268 -34,123	-42%	-$388K	0.01%	1257
2026 Q1	$914K	Buy	80,391 +12,436	+18%	+$135K	0.02%	1072
2025 Q4	$873K	Buy	67,955 +4,037	+6%	+$49.8K	0.02%	1034
2025 Q3	$714K	Sell	63,918 -160,596	-72%	-$1.55M	0.02%	1123
2025 Q2	$2.23M	Buy	224,514 +201,843	+890%	+$1.98M	0.05%	553
2025 Q1	$213K	Buy	+22,671	New	+$238K	0.01%	1037
2024 Q4	–	Sell	-36,006	Closed	-$280K	–	1152
2024 Q3	$280K	Buy	+36,006	New	+$260K	0.02%	1046
2024 Q2	–	Sell	-41,926	Closed	-$246K	–	1366
2024 Q1	$246K	Buy	41,926 +28,336	+209%	+$168K	0.02%	1058
2023 Q4	$107K	Sell	13,590 -17,589	-56%	-$122K	0.01%	1087
2023 Q3	$228K	Buy	+31,179	New	+$259K	0.02%	873

Other funds holding ANGO

MNBTD

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Y-Intercept (HK)'s ANGO Position: Q2 2026 in Review

Y-Intercept (HK) reduced its AngioDynamics (ANGO) stake by 42% in Q2 2026, selling an estimated $388K and leaving 46,268 shares worth $602K. The position accounts for 0.01% of the portfolio, ranked #1257.

Y-Intercept (HK) first reported a position in ANGO in Q3 2023 and has held it in 10 quarters since. The position peaked at $2.23M in Q2 2025. 17 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

Y-Intercept (HK) held 46,268 shares of AngioDynamics worth $602K as of Q2 2026.
Y-Intercept (HK) sold 34,123 AngioDynamics shares in Q2 2026, an estimated $388K.
AngioDynamics made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1257 holding.
Y-Intercept (HK) first reported a position in AngioDynamics in Q3 2023 and has held it in 10 quarters since.
Y-Intercept (HK)'s AngioDynamics position peaked at $2.23M in Q2 2025.
17 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.